{"transactions":[{"id":1399,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":1152,"kind":"person","name":"Teplitsky Liane Rae","position":1,"cik":"0002132552","reported_name":"Teplitsky Liane Rae","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-02T23:38:50.000Z","date":"2026-09-01","kind":"purchase","planned":false,"acquired":true,"shares":1001,"price":49.95,"value":49999.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"shares","element":"transactionShares","label":"F2","text":"The purchase of fractional shares has been rounded down to the nearest whole number."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market purchase transactions made on the same day at the same price through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred at the reported price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The purchase of fractional shares has been rounded down to the nearest whole number."}],"balance_after":4095,"source":{"system":"sec-edgar","filing":"0001437749-26-029545","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2132552/000143774926029545/rdgdoc.xml","form_type":"4"}},{"id":1398,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":1152,"kind":"person","name":"Teplitsky Liane Rae","position":1,"cik":"0002132552","reported_name":"Teplitsky Liane Rae","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-02T23:38:50.000Z","date":"2026-08-31","kind":"purchase","planned":false,"acquired":true,"shares":1024,"price":48.8,"value":49971.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"shares","element":"transactionShares","label":"F2","text":"The purchase of fractional shares has been rounded down to the nearest whole number."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $48.76 to $48.80 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The purchase of fractional shares has been rounded down to the nearest whole number."}],"balance_after":3094,"source":{"system":"sec-edgar","filing":"0001437749-26-029545","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2132552/000143774926029545/rdgdoc.xml","form_type":"4"}},{"id":672749,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":1152,"kind":"person","name":"Teplitsky Liane Rae","position":1,"cik":"0002132552","reported_name":"Teplitsky Liane Rae","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-28T19:48:48.000Z","date":"2026-08-28","kind":"purchase","planned":false,"acquired":true,"shares":1034,"price":48.35,"value":49993.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"shares","element":"transactionShares","label":"F2","text":"The purchase of fractional shares has been rounded down to the nearest whole number."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market purchase transactions made on the same day at the same price through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred at the reported price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The purchase of fractional shares has been rounded down to the nearest whole number."}],"balance_after":2070,"source":{"system":"sec-edgar","filing":"0001437749-26-029233","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926029233/rdgdoc.xml","form_type":"4"}},{"id":672748,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":1152,"kind":"person","name":"Teplitsky Liane Rae","position":1,"cik":"0002132552","reported_name":"Teplitsky Liane Rae","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-28T19:48:48.000Z","date":"2026-08-26","kind":"purchase","planned":false,"acquired":true,"shares":1036,"price":48.235,"value":49971.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"shares","element":"transactionShares","label":"F2","text":"The purchase of fractional shares has been rounded down to the nearest whole number."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market purchase transactions made on the same day at the same price through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred at the reported price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The purchase of fractional shares has been rounded down to the nearest whole number."}],"balance_after":1036,"source":{"system":"sec-edgar","filing":"0001437749-26-029233","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926029233/rdgdoc.xml","form_type":"4"}},{"id":672747,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":1152,"kind":"person","name":"Teplitsky Liane Rae","position":1,"cik":"0002132552","reported_name":"Teplitsky Liane Rae","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-28T19:45:29.000Z","date":"2026-08-08","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Two sevenths of the shares subject to the option will vest in equal installments on the first, second, third, and fourth anniversaries of the grant date and the remaining shares subject to the option will vest in equal tranches upon the achievement of three performance-based vesting criteria tied to both the Issuer's market capitalization ranging from $2 billion to $5 billion and GAAP product revenue targets ranging from $100 million to $330 million, in all cases, subject to the Reporting Person's continued service through each vesting milestone."}],"balance_after":700000,"derivative":{"exercise_price":19.06,"expiration_date":"2036-08-08","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001437749-26-029231","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926029231/rdgdoc.xml","form_type":"4"}},{"id":672746,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":1152,"kind":"person","name":"Teplitsky Liane Rae","position":1,"cik":"0002132552","reported_name":"Teplitsky Liane Rae","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-28T19:45:29.000Z","date":"2026-08-08","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest upon certain performance-based criteria established by the Board of Directors."}],"balance_after":200000,"derivative":{"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-26-029231","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926029231/rdgdoc.xml","form_type":"4"}},{"id":672745,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":18644,"kind":"person","name":"Skinner Jon","position":1,"cik":"0002078637","reported_name":"Skinner Jon","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-28T19:17:14.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Half of the shares subject to the option will vest in equal installments on the first, second, third, and fourth anniversaries of the grant date and the remaining shares subject to the option will vest in equal tranches upon the achievement of four performance-based vesting criteria tied to both the Issuer's market capitalization ranging from $2 billion to $5 billion and GAAP revenue targets ranging from $48 million to $175 million, in all cases, subject to the Reporting Person's continued service through each vesting milestone."}],"balance_after":300000,"derivative":{"exercise_price":20.93,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001437749-26-029220","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926029220/rdgdoc.xml","form_type":"4"}},{"id":737505,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:21:58.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":14504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026."}],"balance_after":14504,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":14504},"source":{"system":"sec-edgar","filing":"0001437749-26-020722","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774926020722/rdgdoc.xml","form_type":"4"}},{"id":737504,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:21:58.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026."}],"balance_after":30000,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-020722","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774926020722/rdgdoc.xml","form_type":"4"}},{"id":737692,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:06:48.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":8423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026."}],"balance_after":8423,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":8423},"source":{"system":"sec-edgar","filing":"0001437749-26-020719","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774926020719/rdgdoc.xml","form_type":"4"}},{"id":737691,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:06:48.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026."}],"balance_after":30000,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-020719","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774926020719/rdgdoc.xml","form_type":"4"}},{"id":738326,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:05:43.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":12495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026."}],"balance_after":12495,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":12495},"source":{"system":"sec-edgar","filing":"0001437749-26-020717","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774926020717/rdgdoc.xml","form_type":"4"}},{"id":738325,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:05:43.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026."}],"balance_after":30000,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-020717","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774926020717/rdgdoc.xml","form_type":"4"}},{"id":737450,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38041,"kind":"person","name":"Soni Manmeet Singh","position":1,"cik":"0001569769","reported_name":"Soni Manmeet Singh","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:03:05.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026."}],"balance_after":30000,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-020715","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1569769/000143774926020715/rdgdoc.xml","form_type":"4"}},{"id":737711,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T00:54:57.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":3793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026."}],"balance_after":3793,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":3793},"source":{"system":"sec-edgar","filing":"0001437749-26-020713","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000143774926020713/rdgdoc.xml","form_type":"4"}},{"id":737710,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T00:54:57.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026."}],"balance_after":30000,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-020713","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000143774926020713/rdgdoc.xml","form_type":"4"}},{"id":777619,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-05-15T23:25:26.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":660233,"price":19.69,"value":12999987.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes approximately 700 shares inadvertently not reported in the Company's Schedule 14A filed on May 11, 2026."}],"balance_after":48370047,"source":{"system":"sec-edgar","filing":"0001437749-26-017478","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774926017478/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-05-11"}},{"id":784510,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":48303,"kind":"person","name":"LAVIOLETTE PAUL A","position":1,"cik":"0001191249","reported_name":"LAVIOLETTE PAUL A","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-12T00:52:41.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":19.69,"value":295350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares reported herein were acquired in a negotiated through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares purchased through the Company's Employee Stock Purchase Plan in March 2026."}],"balance_after":15846,"source":{"system":"sec-edgar","filing":"0001437749-26-016208","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191249/000143774926016208/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-05-11"}},{"id":784509,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":48303,"kind":"person","name":"LAVIOLETTE PAUL A","position":1,"cik":"0001191249","reported_name":"LAVIOLETTE PAUL A","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-11T22:53:24.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":19.69,"value":295350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares reported herein were acquired in a negotiated through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001437749-26-016190","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191249/000143774926016190/rdgdoc.xml","form_type":"4"}},{"id":785328,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-05-11T22:52:09.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":660233,"price":19.69,"value":12999987.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale."}],"balance_after":48211433,"source":{"system":"sec-edgar","filing":"0001437749-26-016188","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774926016188/rdgdoc.xml","form_type":"4"}},{"id":815927,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-03T21:27:51.000Z","date":"2026-03-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will fully vest on March 23, 2029, the three-year anniversary of the grant, subject to the Reporting Person's continued service through to that date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will fully vest on March 23, 2029, the three-year anniversary of the grant, subject to the Reporting Person's continued service through to that date."}],"balance_after":100000,"derivative":{"exercise_date":"2029-03-23","expiration_date":"2029-03-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-26-011291","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774926011291/rdgdoc.xml","form_type":"4"}},{"id":887468,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-24T01:55:39.000Z","date":"2026-02-18","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":300000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001437749-26-005144","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926005144/rdgdoc.xml","form_type":"4"}},{"id":887467,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:55:39.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":23.64,"value":118200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $22.40 to $24.40 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-005144","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926005144/rdgdoc.xml","form_type":"4"}},{"id":887466,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:55:39.000Z","date":"2026-02-18","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":48298,"source":{"system":"sec-edgar","filing":"0001437749-26-005144","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926005144/rdgdoc.xml","form_type":"4"}},{"id":900331,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":305000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900330,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":325000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900329,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":345000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900328,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":23.63,"value":472600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $22.98 to $24.99 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900327,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900326,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":23.53,"value":470600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.00 to $25.00 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900325,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900324,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":23.37,"value":467400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $22.81 to $26.00 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900323,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":909509,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-11","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":365000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909508,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-10","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":385000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909507,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":405000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909506,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-11","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":25.2,"value":504000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.36 to $26.36 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909505,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-11","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909504,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-10","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":23.52,"value":470400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.00 to $26.08 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909503,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-10","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909502,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":21.45,"value":429000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $21.00 to $23.22 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909501,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":915918,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-02-07T02:21:10.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":3104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal installments on March 5, 2026 and June 5, 2026, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":3104,"derivative":{"exercise_price":13.69,"expiration_date":"2036-02-05","underlying":"Common Stock","underlying_shares":3104},"source":{"system":"sec-edgar","filing":"0001437749-26-003395","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000143774926003395/rdgdoc.xml","form_type":"4"}},{"id":915917,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-02-07T02:21:10.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option will vest on the one-year anniversary of the grant and the remaining shares will vest on a monthly basis over two years thereafter, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":14.72,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-26-003395","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000143774926003395/rdgdoc.xml","form_type":"4"}},{"id":1021959,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-07T23:18:44.000Z","date":"2025-10-02","kind":"exercise","planned":true,"acquired":false,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":425000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001437749-25-030665","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925030665/rdgdoc.xml","form_type":"4"}},{"id":1021958,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T23:18:44.000Z","date":"2025-10-02","kind":"sale","planned":true,"acquired":false,"shares":4600,"price":18.53,"value":85238.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $18.48 to $18.65 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-25-030665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925030665/rdgdoc.xml","form_type":"4"}},{"id":1021957,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T23:18:44.000Z","date":"2025-10-02","kind":"exercise","planned":true,"acquired":true,"shares":4600,"price":1.53,"value":7038.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":47898,"source":{"system":"sec-edgar","filing":"0001437749-25-030665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925030665/rdgdoc.xml","form_type":"4"}},{"id":1034202,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-19","kind":"exercise","planned":true,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":429600,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034201,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-18","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":430000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034200,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-19","kind":"sale","planned":true,"acquired":false,"shares":400,"price":18.48,"value":7392.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034199,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-19","kind":"exercise","planned":true,"acquired":true,"shares":400,"price":1.53,"value":612.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":43698,"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034198,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-18","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":18.49,"value":369800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $18.48 to $19.48 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034197,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-18","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1036181,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Incentive stock options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036180,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":false,"shares":61534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":61534},"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036179,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":61534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036178,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-16","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":81534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036177,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":4,"value":400000.0,"ownership":{"direct":true},"balance_after":284406,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036176,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":true,"shares":61534,"price":4,"value":246136.0,"ownership":{"direct":true},"balance_after":184406,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036175,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":16.21,"value":324200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $16.00 to $16.44 per share."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036174,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":4,"value":80000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":142872,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036173,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":16.28,"value":407000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.49 to $16.78 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036172,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-16","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":147872,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1040221,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":106534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040220,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-12","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":131534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040219,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-11","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":156534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040218,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":15.77,"value":394250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.18 to $17.20 per share."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040217,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":147872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040216,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-12","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":14.32,"value":358000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $13.80 to $14.76 per share."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040215,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-12","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":147872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040214,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-11","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":14.78,"value":369500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $14.41 to $15.14 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040213,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-11","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":147872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1041917,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-09-13T00:14:18.000Z","date":"2024-09-12","kind":"purchase","planned":false,"acquired":true,"shares":145140,"price":14.41,"value":2091467.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $13.90 to $14.75 per share."}],"balance_after":47709140,"source":{"system":"sec-edgar","filing":"0001437749-25-028988","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925028988/rdgdoc.xml","form_type":"4"}},{"id":1041916,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-09-13T00:14:18.000Z","date":"2024-09-11","kind":"purchase","planned":false,"acquired":true,"shares":12800,"price":14.77,"value":189056.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $14.57 to $14.79 per share."}],"balance_after":47564000,"source":{"system":"sec-edgar","filing":"0001437749-25-028988","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925028988/rdgdoc.xml","form_type":"4"}},{"id":1041915,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-09-13T00:14:18.000Z","date":"2025-09-10","kind":"purchase","planned":false,"acquired":true,"shares":34659,"price":14.66,"value":508100.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $14.51 to $14.81 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":47551200,"source":{"system":"sec-edgar","filing":"0001437749-25-028988","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925028988/rdgdoc.xml","form_type":"4"}},{"id":1061714,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38136,"kind":"person","name":"van den Broek Richard","position":1,"cik":"0001431872","reported_name":"van den Broek Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:38:38.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025."}],"balance_after":30000,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-027401","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431872/000143774925027401/rdgdoc.xml","form_type":"4"}},{"id":1061411,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:23:04.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":24134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2025."}],"balance_after":24134,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":24134},"source":{"system":"sec-edgar","filing":"0001437749-25-027396","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925027396/rdgdoc.xml","form_type":"4"}},{"id":1061410,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:23:04.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025."}],"balance_after":30000,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-027396","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925027396/rdgdoc.xml","form_type":"4"}},{"id":1062732,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:17:31.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":20792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2025."}],"balance_after":20792,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":20792},"source":{"system":"sec-edgar","filing":"0001437749-25-027394","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925027394/rdgdoc.xml","form_type":"4"}},{"id":1062731,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:17:31.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025."}],"balance_after":30000,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-027394","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925027394/rdgdoc.xml","form_type":"4"}},{"id":1061287,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38041,"kind":"person","name":"Soni Manmeet Singh","position":1,"cik":"0001569769","reported_name":"Soni Manmeet Singh","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:13:40.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025."}],"balance_after":30000,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-027392","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1569769/000143774925027392/rdgdoc.xml","form_type":"4"}},{"id":1086353,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":77459,"kind":"person","name":"Weber Steven","position":1,"cik":"0001844594","reported_name":"Weber Steven","relationship":{"officer":true,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-16T22:26:07.000Z","date":"2025-07-14","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Half of the shares subject to the option will vest in equal installments on the first, second, third, and fourth anniversaries of the grant date and the remaining shares subject to the option will vest in equal tranches upon the achievement of four performance-based vesting criteria tied to the Issuer's market capitalization ranging from $1.5 billion to $4.0 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone."}],"balance_after":55000,"derivative":{"exercise_price":16.03,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001437749-25-022853","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925022853/rdgdoc.xml","form_type":"4"}},{"id":1109569,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-06-17T00:23:49.000Z","date":"2025-06-13","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":15.98,"value":239700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.90 to $16.04 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-020563","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925020563/rdgdoc.xml","form_type":"4"}},{"id":1109568,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-06-17T00:23:49.000Z","date":"2025-06-12","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":16.4,"value":246000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $16.32 to $16.57 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":137872,"source":{"system":"sec-edgar","filing":"0001437749-25-020563","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925020563/rdgdoc.xml","form_type":"4"}},{"id":1273541,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2025-02-11T23:20:57.000Z","date":"2025-02-03","kind":"other","planned":false,"acquired":false,"shares":30121,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":30121},"source":{"system":"sec-edgar","filing":"0001437749-25-003449","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925003449/rdgdoc.xml","form_type":"4"}},{"id":1273540,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2025-02-11T23:20:57.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":false,"shares":30121,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":30121},"source":{"system":"sec-edgar","filing":"0001437749-25-003449","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925003449/rdgdoc.xml","form_type":"4"}},{"id":1273539,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-11T23:20:57.000Z","date":"2025-02-03","kind":"other","planned":false,"acquired":true,"shares":30121,"price":11,"value":331331.0,"ownership":{"direct":true},"balance_after":725395,"source":{"system":"sec-edgar","filing":"0001437749-25-003449","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925003449/rdgdoc.xml","form_type":"4"}},{"id":1273538,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-11T23:20:57.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":true,"shares":30121,"price":11,"value":331331.0,"ownership":{"direct":true},"balance_after":695274,"source":{"system":"sec-edgar","filing":"0001437749-25-003449","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925003449/rdgdoc.xml","form_type":"4"}},{"id":1304201,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":48303,"kind":"person","name":"LAVIOLETTE PAUL A","position":1,"cik":"0001191249","reported_name":"LAVIOLETTE PAUL A","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-14T00:45:33.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are subject to five tranches of performance-based vesting criteria tied to certain operating targets and the Issuer's market capitalization ranging from $3 billion to $9 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone."}],"balance_after":1050000,"derivative":{"exercise_price":18.43,"expiration_date":"2035-01-09","underlying":"Common Stock","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0001437749-25-001016","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191249/000143774925001016/rdgdoc.xml","form_type":"4"}},{"id":1304200,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":48303,"kind":"person","name":"LAVIOLETTE PAUL A","position":1,"cik":"0001191249","reported_name":"LAVIOLETTE PAUL A","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-14T00:45:33.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option will vest on the three-year anniversary of the grant and the remaining shares will vest on the four-year anniversary of the grant, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":450000,"derivative":{"exercise_price":18.43,"expiration_date":"2035-01-09","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001437749-25-001016","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191249/000143774925001016/rdgdoc.xml","form_type":"4"}},{"id":1324415,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":84876,"kind":"person","name":"Barrett Burke Thomas","position":1,"cik":"0002023875","reported_name":"Barrett Burke Thomas","relationship":{"other":true,"other_text":"Former President and CEO"}}],"security":"Common Stock","published_at":"2024-12-20T17:00:42.000Z","date":"2024-12-11","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":17.42,"value":871000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As part of this transaction, Mr. Barrett has agreed to voluntarily disgorge the short swing profits realized by Mr. Barrett as a result of the sale of shares disclosed hereby and his prior purchase of 1,086 units in the Company's right's offering earlier this year. Prior to filing this Form 4, Mr. Barrett contacted the Issuer to make arrangements for payment of such disgorgement."}],"balance_after":63172,"source":{"system":"sec-edgar","filing":"0001437749-24-038145","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023875/000143774924038145/rdgdoc.xml","form_type":"4"}},{"id":1327227,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":24656,"ownership":{"direct":false,"nature":"Affiliated Company 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and Warrants held by Blazon Corporation, of which the Reporting Person is the sole shareholder."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":24656},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327226,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":24656,"ownership":{"direct":false,"nature":"Affiliated Company 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and Warrants held by Blazon Corporation, of which the Reporting Person is the sole shareholder."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":24656},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327225,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":34510,"ownership":{"direct":false,"nature":"Affiliated Company 1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares and Warrants held by Genius 24C Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":34510},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327224,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":34510,"ownership":{"direct":false,"nature":"Affiliated Company 1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares and Warrants held by Genius 24C Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":34510},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327223,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":2593912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":2593912},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327222,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":2593912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":2593912},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327221,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":true,"shares":49312,"price":11,"value":542432.0,"ownership":{"direct":false,"nature":"Affiliated Company 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2024, the Reporting Person exercised warrants to purchase shares of the Issuer's common stock, at an exercise price of $11.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and Warrants held by Blazon Corporation, of which the Reporting Person is the sole shareholder."}],"balance_after":450189,"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327220,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":true,"shares":69020,"price":11,"value":759220.0,"ownership":{"direct":false,"nature":"Affiliated Company 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2024, the Reporting Person exercised warrants to purchase shares of the Issuer's common stock, at an exercise price of $11.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares and Warrants held by Genius 24C Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":630109,"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327219,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":true,"shares":5187824,"price":11,"value":57066064.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2024, the Reporting Person exercised warrants to purchase shares of the Issuer's common stock, at an exercise price of $11.00 per share."}],"balance_after":47516541,"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}}],"next_cursor":"2024-12-19T02:36:26.000000Z,1327219"}